EH Insights
As we enter the new year, the UK M&A market is showing clear signs of renewed confidence. 2025 closed on a strong footing – setting a positive tone for 2026.
Momentum Builds Heading into 2026
As we enter the new year, the UK M&A market is showing clear signs of renewed confidence. After early concerns around a slow start to 2025, deal activity accelerated through the second half of the year, closing on a strong footing and setting a positive tone for 2026.
According to Mark to Market data, overall UK deal volumes in 2025 were broadly in line with the corresponding period in 2024. However, headline figures only tell part of the story. Beneath the surface, market sentiment improved materially, with transaction momentum building through Q3 and remaining strong into Q4.
For UK business owners with established, profitable companies, this shift matters. Not because the market is “hot,” but because it is disciplined, well-funded and rewarding quality. Owners who prepare properly are securing strong outcomes. Those who delay preparation are finding the market less forgiving.
At Entrepreneurs Hub, we advise owner-managed businesses on how to exit well – and the signals we see across the market are increasingly consistent.
What the Second Half of 2025 Revealed About Buyer Confidence
Despite early caution, M&A activity strengthened significantly in the second half of the year. While volumes finished broadly in line with 2024, the quality and intent behind transactions improved noticeably.
Q3 alone saw £35.4 billion of acquisitions completed, with momentum carrying into Q4. This marked one of the busiest periods for UK private equity dealmaking in several years, reinforcing the UK’s continued appeal to both domestic and international buyers.
Consumer-facing and healthcare businesses were among the most active sectors – not by chance, but because they combine resilience, recurring demand, and long-term growth potential. Businesses with strong fundamentals, defensible market positions and clear growth strategies continued to attract competitive interest, even against a backdrop of wider economic uncertainty.
This mirrors what we see across our own mandates. Buyers are active. Capital is available. But it is being deployed selectively.
Our recent M&A Market Update for Business Owners in the SME Market, explores how buyers are currently assessing opportunities – and why preparation is now a prerequisite, not a competitive advantage.
December 2025: Transaction Overview
December provided a strong close to the year. Around 43% of completed UK transactions were in the B2B sector, with B2C, Financial Services, IT and Healthcare accounting for much of the remaining activity.
This breadth highlights the depth of buyer interest across multiple industries. Well-run businesses in a wide range of sectors are finding buyers – provided they are properly prepared.
Key Trends Shaping The Market
For SME owners, timing a sale is often as important as the deal itself. Early planning allows shareholders to maximise value, create competitive tension and structure transactions that balance certainty at completion with potential future upside.
Timing a Sale Is Strategic – Not Emotional
For many business owners, the business represents a lifetime of work and the majority of personal wealth. Yet too many only begin to think seriously about exit options when prompted by fatigue, health concerns, or unsolicited approaches.
The most successful exits we advise on typically begin two to three years in advance. That timeframe allows owners to:
- Reduce reliance on themselves.
- Strengthen second-tier management.
- Improve quality of earnings and reporting.
- Create competitive tension between buyers.
- Explore multiple exit routes, not just one.
Watch our short video: “10 Tips From Business Owners Who Sold Their Company”.
Hear direct testimony from owners who’ve successfully exited as they share the lessons they learned – and why almost all say they should have started preparing sooner. Press play to learn what they’d do differently.
EH Deal
Guthrie Douglas Acquired by Draper Inc.
The acquisition of Guthrie Douglas by Draper Inc. illustrates several prevailing market themes. This cross-border transaction supported Guthrie Douglas’s long-term growth strategy and reflects growing demand for energy-efficient building technologies.
Its smart shading systems – capable of reducing energy usage by up to 60% – are already specified on landmark projects worldwide. The deal demonstrates how UK businesses operating in sustainability-led niches continue to attract international strategic buyers seeking innovative, scalable platforms.
At Entrepreneurs Hub, we see this repeatedly where owners get a better result because they have have invested time in preparing their business ahead of a sale.
Read the full transaction story to understand what attracted international buyer interest.
Transaction Spotlight
Nordic Climate Group Acquires Allcool (NW) Ltd
Sweden-based Nordic Climate Group has strengthened its UK footprint with the acquisition of Allcool (NW), marking its seventh UK deal since November. The transaction highlights the continued appetite from international buyers for established UK businesses with strong local reputations and long-standing customer relationships.
The deal reflects a wider UK M&A trend, with overseas buyers targeting resilient, regionally strong businesses for long-term growth.
Read the full article in Insider Media and see what this means for UK business owners.
Sector Spotlight: Medical Distribution & MedTech
Medical Distribution and MedTech remain among the most active areas of UK and European M&A, driven by ageing populations, sustained pressure on NHS capacity and the need for innovation-led efficiency gains.
Recent M&A Activity
A selection of notable transactions completed in December highlights the level of strategic and cross-border interest in the sector:
- Van Heek Medical (Netherlands) acquired by Asker Healthcare Group (Sweden)
- Heba (UK) acquired by Joy Memories Inc. (USA)
- MindMaze Therapeutics Holding (Switzerland) acquired by Relief Therapeutics Holding (Switzerland)
- Netlens Scandinavia (Sweden) acquired by Whywet AB (Sweden)
- Cardio Dépôt (France) acquired by Asker Healthcare Group (Sweden)
Strategic buyers continue to target SMEs with specialist IP, strong regulatory compliance and established NHS or international market traction.
Upcoming Events
- Medical Technology UK 2026 11th – 12th March 2026
- Digital Health Rewired 24th-25th March 2026
- NHS Confed Expo 10th-11th June 2026
- HETT Show (Healthcare Excellence Through Technology) 29th– 30th September 2026
Alpha Laboratories Acquired by Diploma plc
Entrepreneurs Hub advised the shareholders of Alpha Laboratories on its acquisition by Diploma plc, a transaction that highlights ongoing consolidation within the medical distribution sector.
Alpha Laboratories is a core supplier of niche medical products to NHS authorities across the UK and serves international private and academic healthcare markets. The business has played a critical role in preventive healthcare through early diagnosis, including involvement in the UK’s Coronavirus testing programme and national screening initiatives such as home testing kits for bowel cancer.
The transaction reflects buyer appetite for high-quality platforms with strong public sector relationships and essential healthcare offerings.
MedTech Sector Report
The UK MedTech sector remains a high-value, high-growth market with sustained M&A activity. This report outlines what acquirers are prioritising – and where businesses most often fall short.
UK Government Signals Renewed Commitment to Life Sciences
In a significant policy development, the UK government has pledged an additional £1.5 billion of investment in medicines, aiming to restore confidence in the life sciences sector and improve patient access to innovative treatments.
Ministers have acknowledged that UK spending on medicines has lagged behind comparable countries and have signalled a review of pricing and reimbursement frameworks to make the UK more attractive for pharmaceutical and MedTech investment. This follows warnings from major pharma companies and paused or cancelled UK investments, with the government keen to prevent capital and innovation migrating to the US and EU.
These signals are contributing to renewed confidence in the UK MedTech and life sciences ecosystem, particularly for businesses aligned with innovation, specialist medicines, and NHS efficiency objectives.
“This signals a shift in UK healthcare policy, with government recognising that sustained underinvestment in medicines risks eroding the UK’s life sciences ecosystem. For executives and investors, this strengthens the medium-term case for UK healthcare assets, particularly those aligned to innovation, specialist medicines and NHS efficiency gains.”
Proof Comes from Outcomes – Not Commentary
Anyone can comment on the market. What matters is execution.
Our success stories demonstrate how preparation, positioning and disciplined deal management translate into real results – whether that’s a full exit, partial sale or phased succession. Across these transactions, the pattern is consistent: owners who prepare early achieve better outcomes and retain more control.
Looking Ahead
As we move into 2026, the outlook for UK M&A is increasingly constructive. Capital remains available, buyer confidence is improving, and sector fundamentals – particularly across healthcare, consumer and B2B services – remain supportive.
For business owners considering succession or an exit, now is an opportune time to assess options, begin planning and engage with advisers early. Preparation remains the single most effective way to maximise value and ensure a successful outcome.
In the next edition of EH Insights, we will highlight another sector where we see consistent demand, strong transaction momentum, and attractive outcomes for well-prepared owners – providing practical, owner-focused insight into how buyers are thinking and what drives valuation.
If you would like to discuss market conditions, succession planning or the right timing for a potential transaction – please get in touch with our team for a confidential conversation.